David Greenwood

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

Journal: EBioMedicine

Published: March 16, 2026

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.

Journal: The Journal of infection

Published: July 18, 2025

SARS-CoV-2 antibody immunity across three continents: the West Africa, West Indies, West London Consortium.

SARS-CoV-2 antibody immunity across three continents: the West Africa, West Indies, West London Consortium.

Journal: medRxiv : the preprint server for health sciences

Published: June 30, 2025

Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis.

Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis.

Journal: BMJ neurology open

Published: June 11, 2025

Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021-2024.

Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021-2024.

Journal: Emerging infectious diseases

Published: May 29, 2025

Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.

Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.

Journal: Vaccine

Published: December 04, 2024

Chronogram: an R package for data curation and analysis of infection and vaccination cohort studies.

Chronogram: an R package for data curation and analysis of infection and vaccination cohort studies.

Journal: Bioinformatics advances

Published: June 13, 2024

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

Journal: The Lancet. Infectious diseases

Published: April 11, 2024

Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.

Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.

Journal: Lancet (London, England)

Published: January 05, 2024

Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation.

Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation.

Journal: Frontiers in immunology

Published: November 03, 2023

SARS-CoV-2 mucosal neutralising immunity after vaccination.

SARS-CoV-2 mucosal neutralising immunity after vaccination.

Journal: The Lancet. Infectious diseases

Published: August 25, 2023

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.

Journal: PloS one

Published: March 10, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026